Sfoglia per AUTORE
BOZ C
Collezione ASL Torino 4

  

Items : 13

Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study. in Neurology / Neurology. 2022 Jun 14;98(24):e2401-e2412. doi: 10.1212/WNL.0000000000200545. Epub 2022 Apr 11.

2022
ASL Torino 4

Kubala Havrdova E; Horakova D; Malpas C; Diouf I; Vitkova M; Patti F; Ozakbas S; Izquierdo G; Eichau S; Shaygannejad V; Onofrj M; Lugaresi A; Alroughani R; Prat A; Larochelle C; Girard M; Duquette P; Terzi M; Boz C; Grand'Maison F; Sola P; Ferraro D; Grammond P; Butzkueven H; Buzzard K; Skibina O; Yamout BI; Karabudak R; Gerlach O; et alii...

Confirmed disability progression as a marker of permanent disability in multiple sclerosis. in European journal of neurology / Eur J Neurol. 2022 Aug;29(8):2321-2334. doi: 10.1111/ene.15406. Epub 2022 Jun 9.

2022
ASL Torino 4

Boz C; Shaygannejad V; van Pesch V; Cartechini E; Kappos L; Lechner-Scott J; Bergamaschi R; Lugaresi A; Grand'Maison F; Grammond P; Sola P; Ferraro D; Terzi M; Gerlach O; Alroughani R; Eichau S; Trojano M; Prat A; Girard M; Duquette P; Onofrj M; Sharmin S; Bovis F; Malpas C; Horakova D; Havrdova EK; Izquierdo G; Macdonell R; Dominguez JA; et alii...

Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2022 Apr 3:13524585221084577. doi: 10.1177/13524585221084577.

2022
ASL Torino 4

Kalincik T; Kister I; Bacon TE; Malpas CB; Sharmin S; Horakova D; Kubala-Havrdova E; Patti F; Izquierdo G; Eichau S; Ozakbas S; Onofrj M; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Sola P; Ferraro D; Alroughani R; Terzi M; Boz C; Grand'Maison F; Bergamaschi R; Gerlach O; Sa MJ; Kappos L; Cartechini E; Lechner-Scott J; et alii...

Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registry. in Journal of the neurological sciences / J Neurol Sci. 2021 Nov 15;430:118067. doi: 10.1016/j.jns.2021.118067. Epub 2021 Sep 3.

2021
ASL Torino 4

Kenney R; Liu M; Patil S; Alroughani R; Ampapa R; Bergamaschi R; Boz C; Butzkueven H; Gomez JC; Cartechini E; Madueño SE; Ferraro D; Grand-Maison F; Granella F; Horakova D; Izquierdo Ayuso G; Kalincik T; Lizrova Preiningerova J; Lugaresi A; Onofrj M; Ozakbas S; Patti F; Sola P; Soysal A; Spitaleri DLA; Terzi M; Turkoglu R; van Pesch V; Saidha S; et alii...

Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2021 Apr;27(5):695-705. doi: 10.1177/1352458520936823. Epub 2020 Jul 8.

2021
ASL Torino 4

Kunchok A; Lechner-Scott J; Granella F; Trojano M; Alroughani R; Sola P; Ferraro D; Lugaresi A; Onofrj M; Ozakbas S; Izquierdo G; Grammond P; Luis Sanchez-Menoyo J; Van Wijmeersch B; Boz C; Pucci E; McCombe P; Grand'Maison F; Spitaleri D; Vucic S; Hupperts R; Jokubaitis V; Sormani MP; Butzkueven H; Kalincik T;

Early clinical markers of aggressive multiple sclerosis. in Brain : a journal of neurology / Brain. 2020 May 1;143(5):1400-1413. doi: 10.1093/brain/awaa081.

2020
ASL Torino 4

Malpas CB; Manouchehrinia A; Sharmin S; Roos I; Horakova D; Havrdova EK; Trojano M; Izquierdo G; Eichau S; Bergamaschi R; Sola P; Ferraro D; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Grand'Maison F; Ozakbas S; Van Pesch V; Granella F; Hupperts R; Pucci E; Boz C; Sidhom Y; Gouider R; Spitaleri D; Soysal A; Petersen T; et alii...

Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2020 Feb;38:101868. doi: 10.1016/j.msard.2019.101868. Epub 2019 Nov 25.

2020
ASL Torino 4

Kunchok A; Malpas C; Nytrova P; Havrdova EK; Alroughani R; Terzi M; Yamout B; Hor JY; Karabudak R; Boz C; Ozakbas S; Olascoaga J; Simo M; Granella F; Patti F; McCombe P; Csepany T; Singhal B; Bergamaschi R; Fragoso Y; Al-Harbi T; Turkoglu R; Lechner-Scott J; Laureys G; Oreja-Guevara C; Pucci E; Sola P; Ferraro D; Altintas A; et alii...

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):458-468. doi: 10.1136/jnnp-2018-319831. Epub 2019 Jan

2019
ASL Torino 4

Kalincik T; Kubala Havrdova E; Horakova D; Izquierdo G; Prat A; Girard M; Duquette P; Grammond P; Onofrj M; Lugaresi A; Ozakbas S; Kappos L; Kuhle J; Terzi M; Lechner-Scott J; Boz C; Grand'Maison F; Prevost J; Sola P; Ferraro D; Granella F; Trojano M; Bergamaschi R; Pucci E; Turkoglu R; McCombe PA; Pesch VV; Van Wijmeersch B; Solaro C; et alii...

Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis. in JAMA neurology / JAMA Neurol. 2018 Nov 1;75(11):1407-1415. doi: 10.1001/jamaneurol.2018.2109.

2018
ASL Torino 4

Hughes J; Jokubaitis V; Lugaresi A; Hupperts R; Izquierdo G; Prat A; Girard M; Duquette P; Grand'Maison F; Grammond P; Sola P; Ferraro D; Ramo-Tello C; Trojano M; Slee M; Shaygannejad V; Boz C; Lechner-Scott J; Van Pesch V; Pucci E; Solaro C; Verheul F; Terzi M; Granella F; Spitaleri D; Alroughani R; Jun JK; Fambiatos A; Van der Walt A; et alii...

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2018 Apr;24(5):642-652. doi: 10.1177/1352458517703800. Epub 2017 Apr 6.

2018
ASL Torino 4

Signori A; Izquierdo G; Lugaresi A; Hupperts R; Grand'Maison F; Sola P; Horakova D; Havrdova E; Prat A; Girard M; Duquette P; Boz C; Grammond P; Terzi M; Singhal B; Alroughani R; Petersen T; Ramo C; Oreja-Guevara C; Spitaleri D; Shaygannejad V; Butzkueven H; Kalincik T; Jokubaitis V; Slee M; Fernandez Bolaños R; Sanchez-Menoyo JL; Pucci E; Granella F; et alii...

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response. in Brain : a journal of neurology / Brain. 2017 Sep 1;140(9):2426-2443. doi: 10.1093/brain/awx185.

2017
ASL Torino 4

Kalincik T; Manouchehrinia A; Sobisek L; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Izquierdo G; Lugaresi A; Girard M; Prat A; Duquette P; Grammond P; Sola P; Hupperts R; Grand'Maison F; Pucci E; Boz C; Alroughani R; Van Pesch V; Lechner-Scott J; Terzi M; Bergamaschi R; Iuliano G; Granella F; Spitaleri D; Shaygannejad V; Oreja-Guevara C; et alii...

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study. in The Lancet. Neurology / Lancet Neurol. 2017 Apr;16(4):271-281. doi: 10.1016/S1474-4422(17)30007-8. Epub 2017 Feb 11.

2017
ASL Torino 4

Kalincik T; Brown JWL; Robertson N; Willis M; Scolding N; Rice CM; Wilkins A; Pearson O; Ziemssen T; Hutchinson M; McGuigan C; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Izquierdo G; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Alroughani R; Pucci E; Sola P; Hupperts R; Lechner-Scott J; Terzi M; Van Pesch V; et alii...

Defining reliable disability outcomes in multiple sclerosis. in Brain : a journal of neurology / Brain. 2015 Nov;138(Pt 11):3287-98. doi: 10.1093/brain/awv258. Epub 2015 Sep 10.

2015
ASL Torino 4

Kalincik T; Cutter G; Spelman T; Jokubaitis V; Havrdova E; Horakova D; Trojano M; Izquierdo G; Girard M; Duquette P; Prat A; Lugaresi A; Grand'Maison F; Grammond P; Hupperts R; Oreja-Guevara C; Boz C; Pucci E; Bergamaschi R; Lechner-Scott J; Alroughani R; Van Pesch V; Iuliano G; Fernandez-Bolaños R; Ramo C; Terzi M; Slee M; Spitaleri D; Verheul F; et alii...